Kumar AH. Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy. BEMS Reports [Internet]. 2021Oct.25 [cited 2024Apr.29];7(2):21-4. Available from: https://www.bemsreports.org/index.php/bems/article/view/116